Eva Renee Barnett, Chief Financial Officer at Immunovant, Inc. (IMVT), sold 5,628 shares at $20.86 ($117K) on 2025-02-19, disclosed to the SEC on 2025-02-21.
Open-market sale of $117k IMVT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.86 | 2,814 | $59K | 50.0% |
| 2 | $20.86 | 2,814 | $59K | 50.0% |
| Total | $20.86 avg | 5,628 | $117K | 100% |
| Filing → |
| IMVT | SELL | 2025-01-17 | $107K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $198K | — | Filing → |
| IMVT | SELL | 2024-11-22 | $212K | — | Filing → |